Marker Therapeutics, Inc. (MRKR)
Largest Insider Buys in Sector
MRKR Stock Price History Chart
MRKR Stock Performance
About Marker Therapeutics, Inc.
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies …
Insider Activity of Marker Therapeutics, Inc.
Over the last 12 months, insiders at Marker Therapeutics, Inc. have bought $0 and sold $0 worth of Marker Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Marker Therapeutics, Inc. have bought $106.52M and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $24,098 was made by Wasserman Frederick Gerald (director) on 2021‑05‑18.
List of Insider Buy and Sell Transactions, Marker Therapeutics, Inc.
| 2021-05-18 | director | 10,000 0.0119% | $2.41 | $24,098 | -43.03% | |||
| 2021-03-16 | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | |||
| 2021-03-16 | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | |||
| 2021-03-16 | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | |||
| 2021-03-16 | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | |||
| 2021-03-16 | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | |||
| 2021-03-16 | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | |||
| 2021-03-16 | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | |||
| 2021-03-16 | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | |||
| 2021-03-16 | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | |||
| 2021-03-16 | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | |||
| 2021-03-16 | director | 1.71M 2.8562% | $1.75 | $3M | -4.30% | |||
| 2021-03-16 | director | 1.14M 1.9041% | $1.75 | $2M | -4.30% | |||
| 2021-03-16 | Chief Development Officer | 571,428 0.9521% | $1.75 | $999,999 | -4.30% | |||
| 2021-03-16 | President and CEO | 142,857 0.238% | $1.75 | $250,000 | -4.30% | |||
| 2021-03-16 | director | 14,285 0.238% | $17.50 | $249,988 | -4.30% | |||
| 2019-08-14 | President and CEO | 10,000 0.0219% | $4.62 | $46,200 | -41.13% | |||
| 2018-05-14 | 10 percent owner | 2.6M 17.57% | $2.40 | $6.24M | +127.00% | |||
| 2011-03-23 | Sale | President and CFO | 320,000 0.4732% | $0.12 | $38,400 | 0.00% |
Insider Historical Profitability
| MAKOWER JOSHUA | 10 percent owner | 10714285 120.0683% | $3.00 | 1 | 0 | <0.0001% |
| SANDELL SCOTT D | 10 percent owner | 10714285 120.0683% | $3.00 | 1 | 0 | <0.0001% |
| BASKETT FOREST | 10 percent owner | 10714285 120.0683% | $3.00 | 1 | 0 | <0.0001% |
| Walker Paul Edward | 10 percent owner | 10714285 120.0683% | $3.00 | 1 | 0 | <0.0001% |
| Sonsini Peter W. | 10 percent owner | 10714285 120.0683% | $3.00 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Nea Management Company Llc | $4.61M | 12.01 | 1.07M | 0% | +$0 | 0.02 | |
| Aisling Capital Management LP | $1.35M | 3.52 | 314,286 | 0% | +$0 | 0.46 | |
| The Vanguard Group | $1M | 2.62 | 233,231 | +3.63% | +$35,148.22 | <0.0001 | |
| Ar Asset Management Inc | $304,000.00 | 0.79 | 70,700 | 0% | +$0 | 0.08 | |
| Geode Capital Management | $288,401.00 | 0.75 | 67,053 | +11.67% | +$30,133.44 | <0.0001 |